SC 13G/A

DOR BIOPHARMA, INC./PAOLO CAVAZZA SCHEDULE 13G/A NO. 1

Company: SOLIGENIX, INC.
Filed: February 13, 2008
Accession Number: 0000950162-08-000093

View Document ↗ View on SEC.gov ↗